SCHEMBL1019184

SCHEMBL1019184

COCCOc1ccc2c(c1)CCN(S(=O)(=O)c1ccc(Oc3ccc(F)cc3)cc1)C2OC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 9/20 0.47
▸ MMP2 P08253 7/20 0.47
▸ MMP7 P09237 5/20 0.47
▸ MMP9 P14780 4/20 0.47
▸ MMP12 P39900 4/20 0.47
▸ MMP14 P50281 4/20 0.47
▸ MMP15 P51511 4/20 0.47
▸ MMP16 P51512 4/20 0.47
▸ MMP26 Q9NRE1 4/20 0.47
▸ TAS2R14 Q9NYV8 2/20 0.45
▸ ESR1 P03372 2/20 0.41
▸ ESR2 Q92731 2/20 0.41
▸ CA1 P00915 3/20 0.41
▸ CA2 P00918 3/20 0.41
▸ CA9 Q16790 3/20 0.41
▸ CA14 Q9ULX7 3/20 0.41
▸ ADAM17 P78536 1/20 0.41
▸ MMP13 P45452 4/20 0.40
▸ MMP3 P08254 3/20 0.40
▸ CA7 P43166 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1024879 0.92 MMP1 (0.46) MMP1MMP2MMP7MMP9MMP12
SCHEMBL1021428 0.91 MMP1 (0.49) MMP1MMP2MMP7MMP9MMP12
SCHEMBL1021498 0.89 ESR1 (0.45) MMP1MMP2MMP7MMP9MMP12
SCHEMBL1021054 0.88 MMP1 (0.43) MMP1MMP2MMP7MMP9MMP12
SCHEMBL1019183 0.88 MMP1 (0.52) MMP1MMP2MMP7MMP9MMP12
SCHEMBL1021841 0.87 ESR1 (0.55) MMP1MMP2MMP7MMP9MMP12
SCHEMBL1022530 0.86 ESR1 (0.47) MMP1MMP2MMP7MMP9MMP12
SCHEMBL3532216 0.85 MMP1 (0.51) MMP1MMP2MMP7MMP9MMP12
SCHEMBL1021792 0.84 TBXAS1 (0.44) MMP1MMP2MMP7MMP9MMP12
SCHEMBL3537910 0.83 MMP1 (0.63) MMP1MMP2MMP7MMP9MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869001-B1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI AVENTIS (FR) 2011-01-12 — — EP disclosed
EP-1869001-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE Sanofi-Aventis (FR) 2007-12-26 — — EP disclosed
WO-2006102998-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI-AVENTIS (DE) 2006-10-05 — — WO disclosed
Send feedback